Skip to content
Subscribe
Submit an Article
Search
  • Home
  • News
  • Videos
  • Conference Coverage
  • Podcasts
  • Home
  • News
  • Videos
  • Conference Coverage
  • Podcasts

Category: Psoriasis

Expert Guidance on the Use of Deucravacitinib (Sotyktu, BMS) in PsO

Lab monitoring is not required for psoriasis patients treated with deucravacitinib (Sotyktu, BMS), according to a new expert consensus panel.

← Previous
Next →

The Journal of Dermatology for Nurse Practitioners (NPs) and Physician Assistants (PAs) or JDNPPA is the only independent, omni-channel resource that is for NPs and PAs and by NPs and PAs.

Linkedin Facebook-f Instagram X-twitter
Quick Links
  • Advertise with Us
  • About Us
  • Advertise with Us
  • About Us

© 2025 All Rights Reserved.